These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26748694)

  • 21. 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study.
    Huang XF; Huang X; Han M; Chen F; Storlien L; Lawrence AJ
    Brain Res; 2004 Aug; 1018(2):227-35. PubMed ID: 15276882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists.
    Chambers JJ; Kurrasch-Orbaugh DM; Parker MA; Nichols DE
    J Med Chem; 2001 Mar; 44(6):1003-10. PubMed ID: 11300881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.
    Bromidge SM; Dabbs S; Davies DT; Davies S; Duckworth DM; Forbes IT; Gaster LM; Ham P; Jones GE; King FD; Mulholland KR; Saunders DV; Wyman PA; Blaney FE; Clarke SE; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Trail B; Riley GJ; Wood MD
    J Med Chem; 2000 Mar; 43(6):1123-34. PubMed ID: 10737744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.
    Acuña-Castillo C; Villalobos C; Moya PR; Sáez P; Cassels BK; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jun; 136(4):510-9. PubMed ID: 12055129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics.
    Lee T; Robichaud AJ; Boyle KE; Lu Y; Robertson DW; Miller KJ; Fitzgerald LW; McElroy JF; Largent BL
    Bioorg Med Chem Lett; 2003 Feb; 13(4):767-70. PubMed ID: 12639577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-affinity relationships of novel small molecule natural product derivatives capable of discriminating between serotonin 5-HT1A, 5-HT2A, 5-HT2C receptor subtypes.
    Cummings DF; Canseco DC; Sheth P; Johnson JE; Schetz JA
    Bioorg Med Chem; 2010 Jul; 18(13):4783-92. PubMed ID: 20570529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice.
    Moya PR; Fox MA; Jensen CL; Laporte JL; French HT; Wendland JR; Murphy DL
    BMC Pharmacol; 2011 Apr; 11():3. PubMed ID: 21473759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and serotonin 5-HT2C receptor activity of ortho- and meta-substituted phenylpiperazines.
    Verdonk ML; Voogd JW; Kanters JA; Kroon J; den Besten R; Brandsma L; Leysen D; Kelder J
    Acta Crystallogr B; 1997 Dec; 53 ( Pt 6)():976-83. PubMed ID: 9436302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)
    Kozell LB; Eshleman AJ; Swanson TL; Bloom SH; Wolfrum KM; Schmachtenberg JL; Olson RJ; Janowsky A; Abbas AI
    J Pharmacol Exp Ther; 2023 Apr; 385(1):62-75. PubMed ID: 36669875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of 5-hydroxytryptamine-induced contraction in the chicken gastrointestinal tract.
    Kitazawa T; Ukai H; Komori S; Taneike T
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):157-68. PubMed ID: 16553644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.
    Kim JY; Kim D; Kang SY; Park WK; Kim HJ; Jung ME; Son EJ; Pae AN; Kim J; Lee J
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6439-42. PubMed ID: 20933409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.
    Shimada I; Maeno K; Kondoh Y; Kaku H; Sugasawa K; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2008 Mar; 16(6):3309-20. PubMed ID: 18083579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
    Su YA; Si TM; Zhou DF; Guo CM; Wang XD; Yang Y; Shu L; Liang JH
    Eur J Pharmacol; 2007 Jun; 564(1-3):123-30. PubMed ID: 17395179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.